← Open Payments lookup

JULIETA ALMAZAN: Open Payments

NPI 1588289532 · TYLER, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,257 in 40 payments from 10 companies in 2025. Trend: 2023 $928 · 2024 $1,112 · 2025 $1,257

Food & beverage: $1,257
CompanyPaymentsAmount
ABBVIE INC.25$406
Janssen Biotech, Inc.2$205
GENZYME CORPORATION6$201
Aimmune Therapeutics, Inc.1$125
Takeda Pharmaceuticals U.S.A., Inc.1$119
Ardelyx, Inc.1$106
Novo Nordisk Inc1$46
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$20
Mirum Pharmaceuticals, Inc.1$14
QOL Medical, LLC1$14

Products named: TREMFYA, DUPIXENT, LINZESS, ZENPEP, ENTYVIO, IBSRELA, RINVOQ, SKYRIZI.

Industry payments across TX — which companies pay providers there.